Dialectical Behavior Therapy in Clinical Practice, Second Edition: Applications across Disorders and Settings

This influential work has now been substantially revised with over 60% new material reflecting over a dozen years of research and clinical advances. Leading experts describe innovative ways to use dialectical behavior therapy (DBT) in a wide range of real-world clinical and community settings. The volume provides wise guidance on setting up, running, and evaluating a comprehensive DBT program. It also presents adaptations designed to meet the needs of particular client populations as time- and cost-effectively as possible. Vivid case examples illustrate diverse applications of DBT for helping adults, adolescents, and children reduce suicidal and self-harming behavior; overcome complex, multiple challenges; and build a life worth living.

New to This Edition
*Presents current best practices for making DBT more efficient and accessible while maximizing program fidelity.
*Chapters on additional populations, including persons with posttraumatic stress disorder and preadolescent children.
*Chapters on additional settings, including milieu-based programs, university counseling centers, and middle and high schools.
*Chapters on pharmacotherapy, promoting employment and self-sufficiency, training and supervision, and DBT beyond Stage 1.

See also Doing Dialectical Behavior Therapy: A Practical Guide, by Kelly Koerner, which demonstrates DBT techniques in detail.

Linda A. Dimeff, PhD, is Chief Scientific Officer at Jaspr Health (www.jasprhealth.com), Institute Director at Portland DBT Institute, and Clinical Faculty in the Department of Psychology at the University of Washington. Since 1994, Dr. Dimeff has collaborated closely with Marsha M. Linehan to develop and evaluate an adaptation of dialectical behavior therapy (DBT) for individuals with substance use disorders and borderline personality disorder; to produce DBT training materials for clinicians; and to train, consult, and supervise clinicians in their practice of DBT. She has worked with public- and private-sector systems throughout the world in their efforts to implement DBT. Dr. Dimeff is a recipient of the Cindy J. Sanderson Outstanding Educator Award from the International Society for the Improvement and Teaching of DBT. She has received over 20 federal grants to facilitate the dissemination of evidence-based therapies and has published over 55 peer-reviewed publications.

Shireen L. Rizvi, PhD, ABPP, is Professor of Psychiatry and Behavioral Sciences at Montefiore Einstein Medical Center in New York, where she serves as Director of Psychology Training and Director of DBT Services and Research. Dr. Rizvi received her doctorate under the mentorship of Marsha M. Linehan. She has received extensive grant funding and published dozens of research papers. Dr. Rizvi is board certified in cognitive and behavioral therapies and DBT. Her mission is to get DBT tools to as many people as possible. Her website is shireenrizvi.com.

Kelly Koerner, PhD, is CEO of Jaspr Health (www.jasprhealth.com) and Clinical Faculty in the Department of Psychology at the University of Washington. Weaving together science, design, and social entrepreneurship, she develops highly collaborative, technology-based solutions to get evidence-based practices (EBPs) to the right point of care. Dr. Koerner has extensive practical experience in supporting individuals and systems as they learn, implement, and sustain EBPs in diverse settings (e.g., from paraprofessionals in juvenile justice facilities, to master’s-level counselors in community mental health and substance abuse treatment centers, to research therapists in academic clinical trials). Most recently, she and her human-centered design team have worked closely with scientists, people with lived experience, and emergency medicine providers to develop a tablet-based application for suicidal people. She maintains an active research program and is a recipient of the Career Achievement Award from the Dissemination and Implementation Science Special Interest Group of the Association for Behavioral and Cognitive Therapies.